Recent Quotes (30 days)

You have no recent quotes
chg | %

Elite Pharmaceuticals Inc  

(Public, OTCMKTS:ELTP)   Watch this stock  
Find more results for elite
0.330
+0.010 (3.13%)
Feb 5 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.31 - 0.34
52 week 0.19 - 0.44
Open 0.32
Vol / Avg. 1.06M/1.14M
Mkt cap 225.97M
P/E 20.31
Div/yield     -
EPS 0.02
Shares 684.76M
Beta 0.92
Inst. own 0%
Feb 10, 2016
Q3 2016 Elite Pharmaceuticals Inc Earnings Call - 11:30AM EST - Add to calendar
Feb 9, 2016
Q3 2016 Elite Pharmaceuticals Inc Earnings Release Add to calendar
Nov 10, 2015
Q2 2016 Elite Pharmaceuticals Inc Earnings Call
  

Key stats and ratios

Q3 (Sep '15) 2015
Net profit margin -229.18% 576.83%
Operating margin -127.86% -329.14%
EBITD margin - -316.83%
Return on average assets -92.42% 115.17%
Return on average equity - -
Employees 36 -
CDP Score - -

Address

165 Ludlow Ave
NORTHVALE, NJ 07647-2305
United States - Map
+1-201-7502646 (Phone)
+1-302-6745266 (Fax)

Website links

Description

Elite Pharmaceuticals, Inc. (Elite) is a specialty pharmaceutical company. The Company is principally engaged in the development and manufacture of oral, controlled-release products. The Company owns, licenses or contract manufactures various products, including phentermine hydrochloric acid (HCl) 37.5 milligram tablets for bariatric, methadone HCl 10 milligram tablets and hydromorphone HCl 8 milligram tablets for pain, phendimetrazine tartrate 35 milligram tablets for bariatric, phentermine HCl 15 milligram and 30 milligram capsules for bariatric, naltrexone HCl 50 milligram tablets for pain, isradipine 2.5 milligram and 5 milligram capsules for cardiovascular diseases, and hydroxyzine HCl 10 milligram, 25 milligram and 50 milligram tablets, which are antihistamines. The Company also owns ELI-200, an undisclosed opioid with sequestered naltrexone capsules. The Company's Northvale Facility operates under current good manufacturing practice (cGMP).

Officers and directors

Nasrat Hakim Chairman of the Board, President, Chief Executive Officer
Age: 54
Carter J. Ward CPA Chief Financial Officer, Treasurer, Secretary
Age: 51
Douglas Plassche Executive Vice President - Operations
Age: 51
Jeenarine Narine Director
Age: 65
Barry H. Dash Ph.D. Independent Director
Age: 84
Jeffrey A. Whitnell CPA Independent Director
Age: 59